Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline
Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity ...
Thursday, May 14, 2026
Tag: Weight loss drugs
Novo CEO Says Wegovy Pill Is Safe and Will Be Widely Available
Novo Nordisk President and CEO Mike Doustdar says Christmas has come early with US approval of its Wegovy weight loss ...
An Obesity shot from Eli Lilly helped some people lose 23% of body weight
A next-generation obesity shot from Eli Lilly helped patients lose nearly a quarter of their body weight, potentially making the ...
President Trump announces deal to reduce cost of weight loss drugs
President Trump delivered remarks from the Oval Office Thursday, announcing a deal with pharmaceutical manufacturers Eli Lilly and Novo Nordisk ...
How Eli Lilly and Novo Nordisk have separated themselves from their rivals
Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior ...
Ozempic Underworld — The Black Market Of Obesity Drugs
A CNBC investigation finds that Novo Nordisk’s Ozempic and Wegovy as well as other wildly popular obesity drugs are being ...
Why Eli Lilly is a top GLP-1 stock: Roundhill CEO
Pharmaceutical companies have significantly grown over the last year as demand for GLP-1 weight-loss drugs continues to skyrocket. Roundhill Investments ...
Novo Shares Drop on Wegovy Sales Miss, Profit Forecast Cut | The Opening Trade 08/07
Japanese stocks soar and the Yen slumps after dovish comments from the BOJ, as the central bank moves to calm ...
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.